Compound ID | 807
Class: Oxazolidinone
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Protein synthesis inhibitor; Effective against MRSA and PRSP |
| Institute where first reported: | Dong-A Pharmaceutical, Republic of Korea |
| Year first mentioned: | 2000 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| External links: | |
| Citation: |